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Abstract 35 
Clinical research should ultimately improve patient care. To enable this, randomized 36 
controlled trials must select, collect, and report outcomes which are both relevant to clinical 37 
practice and genuinely reflect the perspectives of key stakeholders including healthcare 38 
professionals, researchers, and patients. Unfortunately, many randomized controlled trials 39 
fall short of this requirement. Complex issues, including a failure to take into account the 40 
perspectives of key stakeholders when selecting outcomes, variations in outcome definitions 41 
and measurement instruments, and outcome reporting bias make research evidence difficult 42 
to interpret, undermining the translation of research into clinical practice. Problems with poor 43 
outcome selection, measurement, and reporting can be addressed by developing, 44 
disseminating, and implementing core outcome sets. A core outcome set represents a 45 
minimum data set of outcomes developed using robust consensus science methods 46 
engaging diverse stakeholders including healthcare professionals, researchers, and patients. 47 
Core outcomes should be routinely utilized by researchers, collected in a standardized 48 
manner, and reported consistently in the final publication. They are currently being 49 
developed across our specialty including infertility, endometriosis, and preeclampsia. 50 
Recognizing poorly-selected, -collected, and -reported outcomes as serious hindrances to 51 
progress in our specialty, over 80 journals including the American Journal of Obstetrics and 52 
Gynecology, have come together to support the Core Outcomes in Women’s and Newborn 53 
Health (CROWN) initiative. The consortium supports researchers to develop, disseminate, 54 
and implement core outcome sets. Implementing core outcome sets could make a profound 55 
contribution to addressing poorly-selected, -collected, and -reported outcomes. 56 
Implementation should ensure future randomized controlled trials hold the necessary reach 57 
and relevance to inform clinical practice, enhance patient care, and improve patient 58 
outcomes.  59 
Keywords: [1] Core outcome sets; [2] Gynecology; [3] Obstetrics; [4] Outcomes; [5] 60 
Outcome measures; and [6] Research waste.  61 
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The problem:  62 
Research should ultimately improve patient care. For this to be possible, randomized 63 
controlled trials must select, collect, and report outcomes that are relevant to clinical practice 64 
and genuinely reflect the perspectives of diverse stakeholders including professionals, 65 
researchers and patients. 66 
 67 
The solution:  68 
Developing, disseminating, and implementing core outcome sets should standardize 69 
outcome selection, collection, and reporting to ensure future randomized controlled trials 70 
inform clinical practice, enhances patient care, and improves patient outcomes. 71 
 72 
 73 
 74 
 75 
 76 
 77 
 78 
 79 
 80 
 81 
 82 
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Poorly-Selected: Outcomes Lacking Relevance to Clinical Practice and Key 84 
Stakeholders. 85 
Selecting appropriate outcomes is a critical step in designing randomized trials. However, 86 
the relative importance of individual outcomes may become a secondary consideration for 87 
researchers, as they accommodate sample size requirements, costs, and time constraints. 88 
The primary outcome should be the outcome of greatest therapeutic importance to the 89 
study's prospective hypothesis. When considering randomized trials evaluating potential 90 
treatments for infertility, there is a consensus regarding the selection of live birth as the 91 
primary outcome. Unfortunately, a recent systematic review of 142 infertility trials published 92 
in 2013 and 2014 found that only 52 included trials (37%) reported live birth.1 93 
 94 
Poorly-selected outcomes extend beyond the primary outcome. Researchers should select 95 
secondary outcomes which reflect the complex pathophysiology of the healthcare condition 96 
of interest. For example, when considering preeclampsia, secondary outcomes should 97 
include blood pressure thresholds, clinical symptoms, maternal morbidity, and neonatal 98 
morbidity. Many preeclampsia trials fall short of this requirement. A systematic review of 79 99 
preeclampsia trials demonstrated widespread variation in the reporting of outcomes. A 100 
minority of randomised trials reported outcomes concerning maternal morbidity including 101 
eclampsia (39 trials, 49%), pulmonary edema (15 trials, 19%), and renal failure (10 trials, 102 
13%).2 Over the past three decades, the scope of obstetric research has widened, with long‐103 
term childhood follow-up becoming increasingly prioritized by patients, healthcare 104 
professionals, and researchers. As the importance of assessing long‐term outcomes gains 105 
momentum, challenging decisions regarding the selection of long‐term outcomes, follow‐up 106 
duration, and methods will need to be made. 107 
 108 
 109 
 110 
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Poorly-Collected: Different Definitions and Measurement Instruments.  111 
Evidence synthesis can be limited by variation in methods of measurement or definition, 112 
even when outcomes have been consistently collected and reported across trials. In the 113 
absence of a standardized approach, researchers can choose from a variety of different 114 
definitions and measurement instruments. For example, researchers have defined stillbirth 115 
using different combinations of gestational ages, birth weights, and crown-heel lengths. 116 
When considering endometriosis trials, dysmenorrhea has been measured by ten different 117 
measurement instruments including visual analogue scales, Likert scales, and 118 
questionnaires.3 Such variation can make it difficult to synthesize the results of individual 119 
randomized trials using secondary research, including individual patient data meta-analysis, 120 
pair-wise meta-analysis, and network meta-analysis. 121 
 122 
Poorly-Reported: Outcome Reporting Bias. 123 
Outcome reporting bias is defined as the selection for publication of a subset of the original 124 
recorded outcome variables on the basis of the results. Several systematic reviews have 125 
confirmed outcome reporting bias and quantified its impact when pooling data from individual 126 
trials in a meta-analysis. A systematic review of 519 randomized controlled trials identified 127 
substantial deficiencies in outcome reporting: when compared with the trial registry record, 128 
360 trials (75%) did not fully report efficacy outcomes and 196 (64%) did not fully report 129 
harm outcomes in the final trial report.4 Statistically significant outcomes had higher odds of 130 
being fully reported when compared with non-significant outcomes (odds ratio (OR) = 2.0, 131 
95% confidence interval (CI) 1.6 to 2.7). Further problems arise with outcome reporting when 132 
the results of individual trials are combined within a meta-analysis. A systematic review of 133 
157 Cochrane systematic reviews published in 2007, identified more than a third of 134 
systematic reviews contained at least one randomized trial at high risk of outcome reporting 135 
bias.4 A sensitivity analysis, taking into account outcome reporting bias, demonstrated a 136 
reduction of over 20% in the treatment effect of the primary outcome.  137 
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 138 
Problems with poor outcome selection, measurement, and reporting can be addressed by 139 
developing, disseminating, and implementing a core outcome set to standardize outcome 140 
selection, collection, and reporting across future randomized controlled trials within individual 141 
healthcare conditions. 142 
 143 
Call to Action: Developing, Disseminating, and Implementing Core Outcome 144 
Sets. 145 
A core outcome set represents a minimum data set of outcomes developed using robust 146 
consensus science methods. Core outcomes should be consistently selected, collected in a 147 
standardised manner, and reported consistently in the final publication. The existence of a 148 
core outcome set does not imply that outcomes in a particular trial should be restricted. 149 
Rather, there is an expectation that the core outcomes will be collected and reported as a 150 
minimum with other outcomes included as appropriate for a given study. This would make it 151 
easier for the core outcomes from individual trials to be compared, contrasted and combined 152 
as appropriate. Over 50 core outcome sets are currently being developed across our 153 
specialty including infertility, endometriosis, and preeclampsia.5 154 
 155 
When developing a core outcome set, a diverse range of stakeholders, including healthcare 156 
professionals, researchers, and patients, representing various disciplines, geographical 157 
regions, and methodological expertise should be recruited. A high number of varied 158 
participants is desirable to secure the generalizability of the final core outcome set and 159 
increase its credibility with other researchers. 160 
 161 
The first step in core outcome set development is to develop a long list of potential core 162 
outcomes by undertaking a systematic review of published randomized controlled trials 163 
(Figure 1). Outcomes identified through systematic reviews of published trials largely reflect 164 
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outcomes healthcare professionals and researchers have considered important to collect 165 
and measure, particularly where research pre-dates the recent emphasis on patient and 166 
public involvement. Outcomes reported in historic trial reports may not hold the same 167 
relevance for other stakeholders including patients, and, therefore, the evidence base to 168 
support shared decision making is likely to be suboptimal to inform clinical practice. Core 169 
outcome set developers should use qualitative methods to provide reassurance that the long 170 
list of potential core outcomes includes those with relevance to patients. Unfortunately, only 171 
a few core outcome set developers have used in-depth patient interviews to identify relevant 172 
outcomes.5 Future core outcome set developers should engage with methodological 173 
research to evaluate different qualitative methods, including secondary analysis of archive 174 
interviews, focus groups, and free text questionnaires, to identify treatment outcomes that 175 
hold relevance to patients. 176 
 177 
The next step is to reduce the long list of potential core outcomes to a core outcome set 178 
using consensus science methods. Core outcome set developers have used the modified 179 
Delphi method enabling individuals to participate in an iterative process which assesses the 180 
extent of agreement (consensus measurement) and then resolves disagreement (consensus 181 
development).5 Potential core outcomes have been entered into sequential online surveys 182 
through which participants score the importance of individual outcomes. Repeated reflection 183 
and rescoring encourages convergence towards consensus ‘core’ outcomes. 184 
 185 
The final step is to determine how the core outcomes should be defined and measured. 186 
Potential definitions and measurement instruments have been inventoried across formal 187 
definition development initiatives, international and national guidelines, Cochrane systematic 188 
reviews, and randomized controlled trials.5 Such definitions can be entered into a consensus 189 
development workshop to prioritize standardised definitions for individual core outcomes. 190 
Potential measurement instruments have been quality assessed using the Consensus-191 
Based Standards for the Selection of Health Measurement Instruments (COSMIN) initiative 192 
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quality assessment framework in order to associate high-quality measurement instruments 193 
with individual core outcomes.4  194 
 195 
When a core outcome set has been developed it should be regularly reviewed to confirm its 196 
ongoing validity. Future core outcome set developers should carefully design a strategy to 197 
ensure a core outcome set remains fit for purpose. There is uncertainty regarding the 198 
frequency of reviews and whether specific triggers should prompt a review. Methods 199 
including assessments of the uptake of an individual core outcome set, interviews with the 200 
intended users of the core outcome set, and monitoring outcome reporting in future trials 201 
could provide a framework when considering review triggers. 202 
 203 
Core Outcome Sets Supported by Women’s Health Journals. 204 
Embedding core outcome sets within randomized controlled trials could make a profound 205 
contribution to advancing the usefulness of research to inform clinical practice, enhance 206 
patient care, and improve patient outcomes. Recognizing that poorly-selected, -collected, 207 
and -reported outcomes are a serious hindrance to progress in women’s health, over 80 208 
journals, including the American Journal of Obstetrics and Gynecology, have come together 209 
to support the Core Outcomes in Women’s and Newborn Health (CROWN) initiative. The 210 
consortium supports researchers to develop, disseminate, and implement core outcome sets 211 
(Figure 2). Implementing the aims of the CROWN initiative across participating journals 212 
should encourage researchers committed to creating harmony in outcome selection, 213 
collection, and reporting. Over time, research consumers including healthcare professionals, 214 
researchers, and patients, should become accustomed to reviewing complete core outcome 215 
sets in research reports. As a result, the temptation for selective reporting based on 216 
statistical significance should be substantially reduced. Implementation of core outcome sets 217 
is supported by other key stakeholders including opinion leaders, health research funders, 218 
and health research regulators. For example, the Standard Protocol Items: 219 
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Recommendations for Interventional Trials (SPIRIT) statement, implemented by funders of 220 
health research including the National Institutes of Health, European Commission, and the 221 
National Institute of Health Research, recommend the use of core outcome sets wherever 222 
possible.4 Developing collaborative relationships with other stakeholders would be useful, for 223 
example, clinical trial registries, such as clinicaltrials.gov, could mandate the prespecified 224 
collection of individual core outcome sets. 225 
 226 
Conclusions 227 
Developing, disseminating, and implementing core outcome sets could make a profound 228 
contribution to addressing poorly-selected, -collected, and -reported outcomes. 229 
Implementation should ensure that future randomised controlled trials hold the reach and 230 
relevance to inform clinical practice, enhance patient care, and improve patient outcomes. 231 
 232 
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Figure 1. Core outcome set development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stage 3  Determining How Core Outcomes Should Be Measured 
Consensus method  Ensuring outcome measures fit for purpose  
Stage 1  Identifying Potential Core Outcomes  
Systematic review  What outcomes have been reported before?  
Stage 2 Determining Core Outcomes 
Consensus method  Combining professional and patients’ views  
Qualitative research  What outcomes do patients want?   
Core Outcomes Set 
Stage 4  Dissemination       
Stage 5  Implementation        
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Figure 2. Core Outcomes in Women’s and Newborn Health (CROWN) initiative’s aims.17 
 
1. Form a consortium among all gynaecology, obstetrics, and related journals to promote 
core outcome sets in all areas of our specialty. 
2. Encourage researchers to develop core outcome sets using robust consensus 
methodology involving multiple stakeholders, including patients. 
3. Strongly encourage the reporting of results for core outcome sets. 
4. Organize robust peer-review and effective dissemination of manuscripts describing core 
outcome sets. 
5. Facilitate embedding of core outcome sets in research practice, working closely with 
researchers, reviewers, funders and guideline makers. 
 
